- Home
- FRAF vs APLT Comparison
FRAF vs APLT Comparison
Compare FRAF & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRAF
- APLT
- Stock Information
- Founded
- FRAF 1906
- APLT 2016
- Country
- FRAF United States
- APLT United States
- Employees
- FRAF N/A
- APLT 37
- Industry
- FRAF Major Banks
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- FRAF Finance
- APLT Health Care
- Exchange
- FRAF Nasdaq
- APLT Nasdaq
- Market Cap
- FRAF 148.1M
- APLT 128.0M
- IPO Year
- FRAF N/A
- APLT 2019
- Fundamental
- Price
- FRAF $32.98
- APLT $0.97
- Analyst Decision
- FRAF
- APLT Buy
- Analyst Count
- FRAF 0
- APLT 6
- Target Price
- FRAF N/A
- APLT $6.60
- AVG Volume (30 Days)
- FRAF 5.9K
- APLT 10.8M
- Earning Date
- FRAF 01-28-2025
- APLT 11-07-2024
- Dividend Yield
- FRAF 3.87%
- APLT N/A
- EPS Growth
- FRAF 1.58
- APLT N/A
- EPS
- FRAF 3.20
- APLT N/A
- Revenue
- FRAF $71,523,000.00
- APLT N/A
- Revenue This Year
- FRAF N/A
- APLT N/A
- Revenue Next Year
- FRAF N/A
- APLT $5,117.00
- P/E Ratio
- FRAF $10.34
- APLT N/A
- Revenue Growth
- FRAF 8.15
- APLT N/A
- 52 Week Low
- FRAF $25.11
- APLT $1.03
- 52 Week High
- FRAF $34.15
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- FRAF 46.94
- APLT 17.18
- Support Level
- FRAF $32.70
- APLT $1.03
- Resistance Level
- FRAF $33.63
- APLT $1.37
- Average True Range (ATR)
- FRAF 0.45
- APLT 0.19
- MACD
- FRAF -0.15
- APLT -0.08
- Stochastic Oscillator
- FRAF 36.76
- APLT 1.22
About FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals, and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.